Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcusgattii in normal and immunodeficient mice

References

• Khanna N, Chandramuki A, Desai A, et al. Cryptococcosis in the immunocompromised host with special reference to AIDS. Indian J Chest Dis Allied Sci 2000; 42: 311–315
   PubMedGoogle Scholar
• Dromer F, Mathoulin S, Dupont B, Laporte A. Epidemiology of cryptococcosis in France: a 9-year survey (1985–1993). French Cryptococcosis Study Group. Clin Infect Dis 1996; 23: 82–90
   PubMed Web of Science ®Google Scholar
• Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS – 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515–548
   PubMed Web of Science ®Google Scholar
• Casadevall A, Perfect JR. Cryptococcus neoformans. ASM Press, Washington, DC 1998
   Google Scholar
• Sorrell TC. Cryptococcus neoformans variety gattii. Med Mycol 2001; 39: 155–168
   PubMed Web of Science ®Google Scholar
• Speed, B, Dunt, D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21: 28–34; discussion 35–26.
   PubMed Web of Science ®Google Scholar
• Boekhout T, van Belkum A, Leenders AC, et al. Molecular typing of Cryptococcus neoformans: taxonomic and epidemiological aspects. Int J Syst Bacteriol 1997; 47: 432–442
   PubMedGoogle Scholar
• Hoeprich P, Finn P. Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis 1972; 126: 353–361
   PubMed Web of Science ®Google Scholar
• Clemons KV, Azzi R, Stevens DA. Experimental systemic cryptococcosis in SCID mice. J Med Vet Mycol 1996; 34: 331–335
   PubMedGoogle Scholar
• Clemons KV, Brummer E, Stevens DA. Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob Agents Chemother 1994; 38: 460–464
   PubMed Web of Science ®Google Scholar
• Clemons KV, Lutz JE, Stevens DA. Efficacy of recombinant gamma interferon for treatment of systemic cryptococcosis in SCID mice. Antimicrob Agents Chemother 2001; 45: 686–689
   PubMed Web of Science ®Google Scholar
• Clemons KV, Stevens DA. Comparison of Fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis. Antimicrob Agents Chemother 1998; 42: 899–902
   PubMed Web of Science ®Google Scholar
• Lutz JE, Clemons KV, Stevens DA. Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis. J Antimicrob Chemother 2000; 46: 437–442
   PubMed Web of Science ®Google Scholar
• Irokanulo EA, Akueshi CO. Virulence of Cryptococcus neoformans serotypes A, B, C and D for four mouse strains. J Med Microbiol 1995; 43: 289–293
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, Yates JL, Lipscomb MF. T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect Immun 1991; 59: 1423–1433
   PubMed Web of Science ®Google Scholar
• Duncan RA, von Reyn CF, Alliegro GM, et al. Idiopathic CD4+ T-lymphocytopenia – four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med 1993; 328: 393–398
   PubMed Web of Science ®Google Scholar
• Hoag KA, Lipscomb MF, Izzo AA, Street NE. IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am J Respir Cell Mol Biol 1997; 17: 733–739
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 1994; 55: 35–42
   PubMed Web of Science ®Google Scholar
• Rivera J, Zaragoza O, Casadevall A. Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells. Infect Immun 2005; 73: 1141–1150
   PubMed Web of Science ®Google Scholar
• Mukherjee J, Scharff MD, Casadevall A. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun 1992; 60: 4534–4541
   PubMed Web of Science ®Google Scholar
• Beenhouwer DO, Shapiro S, Feldmesser M, Casadevall A, Scharff MD. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infect Immun 2001; 69: 6445–6455
   PubMed Web of Science ®Google Scholar
• Jain N, Li L, McFadden DC, et al. Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system. Infect Immun 2006; 74: 896–903
   PubMed Web of Science ®Google Scholar
• Kwon-Chung KJ, Wickes BL, Stockman L, et al. Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect Immun 1992; 60: 1869–1874
   PubMed Web of Science ®Google Scholar
• Chaturvedi S, Ren P, Narasipura SD, Chaturvedi V. Selection of optimal host strain for molecular pathogenesis studies on Cryptococcus gattii. Mycopathologia 2005; 160: 207–215
   PubMed Web of Science ®Google Scholar
• Cox GM, McDade HC, Chen SC, et al. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 2001; 39: 166–175
   PubMed Web of Science ®Google Scholar
• Zhu X, Williamson PR. Role of laccase in the biology and virulence of Cryptococcus neoformans. FEMS Yeast Res 2004; 5: 1–10
   PubMed Web of Science ®Google Scholar
• Chen SC, Muller M, Zhou JZ, Wright LC, Sorrell TC. Phospholipase activity in Cryptococcus neoformans: a new virulence factor?. J Infect Dis 1997; 175: 414–420
   PubMed Web of Science ®Google Scholar
• Narasipura SD, Chaturvedi V, Chaturvedi S. Characterization of Cryptococcus neoformans variety gattii SOD2 reveals distinct roles of the two superoxide dismutases in fungal biology and virulence. Mol Microbiol 2005; 55: 1782–1800
   PubMed Web of Science ®Google Scholar
• Brummer E, Restrepo A, Hanson LH, Stevens DA. Virulence of Paracoccidioides brasiliensis: the influence of in vitro passage and storage. Mycopathologia 1990; 109: 13–17
   PubMed Web of Science ®Google Scholar
• Stevens DA, Brummer E, DiSalvo AF, Ganer A. Virulent isolates and mutants of Blastomyces in mice: a legacy for studies of pathogenesis. Semin Respir Infect 1997; 12: 189–195
   PubMedGoogle Scholar
• Torda A, Kumar RK, Jones PD. The pathology of human and murine pulmonary infection with Cryptococcus neoformans var. gattii. Pathology 2001; 33: 475–478
   PubMed Web of Science ®Google Scholar
• Torres-Rodriguez JM, Morera Y, Baro T, Corominas JM, Castaneda E. Pathogenicity of Cryptococcus neoformans var. gattii in an immunocompetent mouse model. Med Mycol 2003; 41: 59–63
   PubMed Web of Science ®Google Scholar
• Marquis G, Montplaisir S, Pelletier M, Mousseau S, Auger P. Genetic resistance to murine cryptococcosis: increased susceptibility in the CBA/N XID mutant strain of mice. Infect Immun 1985; 47: 282–287
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, Boyd MB, Street NE, Lipscomb MF. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J Immunol 1998; 160: 2393–2400
   PubMed Web of Science ®Google Scholar
• Hoag KA, Street NE, Huffnagle GB, Lipscomb MF. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J Respir Cell Mol Biol 1995; 13: 487–495
   PubMed Web of Science ®Google Scholar
• Lewis JL, Rabinovich S. The wide spectrum of cryptococcal infections. Am J Med 1972; 53: 315–322
   PubMed Web of Science ®Google Scholar
• Maffei CM, Mirels LF, Sobel RA, Clemons KV, Stevens DA. Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis. Infect Immun 2004; 72: 2338–2349
   PubMed Web of Science ®Google Scholar
• Bodasing N, Seaton RA, Shankland GS, Kennedy D. Cryptococcus neoformans var. gattii meningitis in an HIV-positive patient: first observation in the United Kingdom. J Infect 2004; 49: 253–255
   PubMed Web of Science ®Google Scholar
• Colom MF, Frases S, Ferrer C, et al. First local case of human cryptococcosis in Spain caused by Cryptococcus neoformans var. gattii. Rev Iberoam Micol 2003; 20: 181
   PubMedGoogle Scholar
• Chen S, Sorrell T, Nimmo G, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 2000; 31: 499–508
   PubMed Web of Science ®Google Scholar
• Mitchell DH, Sorrell TC, Allworth AM, et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20: 611–616
   PubMed Web of Science ®Google Scholar
• Salkowski CA, Balish E. Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice. Infect Immun 1990; 58: 3300–3306
   PubMed Web of Science ®Google Scholar
• Kwon-Chung KJ, Bennett JE. Medical Mycology. Lea & Febiger, Philadelphia 1992
   Google Scholar
• Severo LC, Berta EZI, Londero AT. Cutaneous cryptococcosis due to Cryptococcus neoformans var. gattii. Rev Iberoam Micol 2001; 18: 200–201
   PubMedGoogle Scholar
• Christianson JC, Engber W, Andes D. Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts. Med Mycol 2003; 41: 177–188
   PubMed Web of Science ®Google Scholar
• Droitcourt C, Adamski H, Arvieux C, et al. Primary cutaneous cryptococcosis in transplant recipients: a report of two cases. Rev Med Interne 2005; 26: 157–159
   PubMed Web of Science ®Google Scholar
• Kim JH, Shin DH, Oh MD, et al. A case of disseminated cryptococcosis with skin eruption in a patient with acute leukemia. Scand J Infect Dis 2001; 33: 234–235
   PubMedGoogle Scholar
• Chaitowitz M, Shaw ML, Mokoena TR. Gastrointestinal cryptococcosis presenting as spontaneous jejunal perforation in a nonimmunocompromised host. Dig Dis Sci 2003; 48: 1196–1199
   PubMed Web of Science ®Google Scholar
• Sungkanuparph S, Tanphaichitra D, Pracharktam R. Chronic diarrhoea caused by Cryptococcus neoformans in a non-human immunodeficiency virus-infected patient. Scand J Infect Dis 2003; 35: 211–212
   PubMed Web of Science ®Google Scholar
• Washington K, Gottfried MR, Wilson ML. Gastrointestinal cryptococcosis. Mod Pathol 1991; 4: 707–711
   PubMed Web of Science ®Google Scholar
• Dora JM, Kelbert S, Deutschendorf C, et al. Cutaneous cryptococcosis due to Cryptococcus gattii in immunocompetent hosts: Case report and review. Mycopathol 2006; 161: 235–238
   PubMed Web of Science ®Google Scholar